Clinical Trial Update: Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

View source ↗

Summary

A completed trial evaluates the SCOUT noninvasive AGE measurement method for predicting diabetes-related complications in individuals with type 1 or type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: VeraLight, Inc. | Conditions: Type 1 Diabetes, Type 2 Diabetes | Status: COMPLETED